Biogen Announces CFO Transition and Regulation FD Update
Company Announcements

Biogen Announces CFO Transition and Regulation FD Update

Biogen ( (BIIB) ) has shared an announcement.

Biogen Inc. announced the retirement of its Chief Financial Officer, Michael McDonnell, effective February 28, 2025, with Robin Kramer set to succeed him. Kramer, who has been with Biogen since 2018 and currently serves as Chief Accounting Officer, is recognized for her extensive financial expertise and leadership. She is expected to continue advancing Biogen’s strategic initiatives and financial objectives, building on McDonnell’s accomplishments in repositioning the company for growth. Investors may find this leadership transition noteworthy as Biogen continues its focus on sustainable growth and innovation.

For an in-depth examination of BIIB stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyMorning Movers: Caterpillar and Eli Lilly sink following quarterly reports
TheFlySage Therapeutics price target lowered to $8 from $9 at Oppenheimer
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App